This financial data underscores the growing interest in non-invasive neurotech and its potential to disrupt the healthcare industry.
The Regulatory Landscape and Market Strategy
One of the key challenges facing neurotech startups is navigating the complex regulatory landscape. Neurovalens has chosen to focus on obtaining approval from the U.S. food and drug Administration (FDA), which is widely regarded as the gold standard for medical device approval. This strategy not only lends credibility to their products but also opens the door to the massive U.S. healthcare market.